Amgen to open Science and Innovation centre in Hyderabad’s Genome Valley

U.S. biotech major Amgen plans to open a Science and Innovation Centre in Genome Valley, Hyderabad, a decision set to help Telangana strengthen its position as a global life sciences hub.

Expected to be operational in 2027, the facility will bring together scientists and technologists across discovery chemistry, drug metabolism and pharmacokinetics as well as precision medicine. The team will work closely with Amgen’s research sites globally, the firm said on Tuesday after signing an MoU with Telangana government in the presence of IT and Industries Minister D.Sridhar Babu.

Amgen’s global research and development network consists of seven research laboratories. Executive vice-president of R&D, Artificial Intelligence and Data at Amgen Jay Bradner said the new centre would contribute to integration of experimental science, data and technology across Amgen global research capabilities and complement the firm’s strong U.S.-based research and development footprint.”